When COVID-19 vaccines became available in late 2020, Canada faced unprecedented logistics challenges: getting hundreds of millions of doses to hundreds of millions of arms as quickly as possible, with limited initial supply and vast geographic diversity. Vaccine distribution strategy determined who received protection first, how quickly coverage expanded, and whether all Canadians had equitable access. The experience revealed both strengths and weaknesses in Canadian public health infrastructure and offers lessons for future mass vaccination campaigns.